Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Little Green Pharma.
RELATED STOCKHEAD STORIES
News
Banking on pot: Minus one global investment house, Switzerland moves to legalise cannabis
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Goldies cop a beating as investors race back into the arms of the risk monster
Health & Biotech
ASX Health Stocks: TGA’s new ruling has cannabis stocks rushing toward psychedelics – LGP is one of them
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Not even the promise of top-shelf psychedelics could lift the market’s mood
News
ASX Small Caps Lunch Wrap: Who’s riding high on some psychedelic news this morning?
Health & Biotech
Australia just became the first country to recognise psychedelics as medicine. These are the ASX stocks you need to know about
Health & Biotech
Weed Week: Codeine demand drops when recreational cannabis is legal, study finds
News
ASX Earnings Wrap: Tyro rallies 7pc as revenue surges; Baby Bunting crashes 10pc on earnings flop
Health & Biotech
There’s some very good resins why our Little Green Pharma is already leading the 2023 German invasion
Health & Biotech
Weed Week: Aussie companies jostle to become the world’s supplier of medicinal cannabis
Health & Biotech
ASX Health Stocks: Little Green Pharma closing in on first over-the-counter CBD product in Australia
Health & Biotech
ASX Health Stocks: Little Green Pharma ships new cannabis flowers from Denmark to Australia
Health & Biotech
Weed Week: Oregon pardons cannabis convictions and bulk people light up on Turkey Day
Health & Biotech
ASX Health Stocks: Zelira to test its own drug against a Big Pharma’s multi-billion dollar revenue star
Health & Biotech
